Results 21 to 30 of about 538,819 (301)

Assessment of microRNAs in patients with unstable angina pectoris.

open access: yesEuropean Heart Journal, 2014
AIMS While cardiac troponin measurements have significantly improved the early diagnosis of myocardial infarction, the timely biomarker-based diagnosis of unstable angina pectoris (UAP) remains a major unmet clinical challenge.
T. Zeller   +12 more
semanticscholar   +1 more source

Histopathological analysis of the coronary atheroma extracted during coronary artery bypass graft surgery

open access: yesBangabandhu Sheikh Mujib Medical University Journal, 2018
This study aims to evaluate the histopathological analysis as well as the effect of coronary endarterectomy with severe calcified coronary artery disease.
Redoy Ranjan   +5 more
doaj   +1 more source

ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients

open access: yesJournal of the American College of Cardiology, 2002
The American College of Cardiology (ACC)/American Heart Association (AHA) guidelines for the management of unstable angina and non–ST-segment elevation myocardial infarction (UA/NSTEMI) were published in September 2000.1 Since then, a number of clinical ...
E. Braunwald   +22 more
semanticscholar   +1 more source

Diagnostic value of high sensitivity C-reactive protein in differentiating unstable angina from myocardial infarction

open access: yesChronic Diseases Journal, 2013
BACKGROUND: Differentiating between unstable angina and myocardial infarction (MI) is clinically important as they require different treatments. High sensitivity C-reactive protein (hs-CRP) has recently been recognized as prognostic factor in acute ...
Reza Madadi   +3 more
doaj   +1 more source

Unstable Angina Biomarkers and Their Main Risk Factors in Iraqi Patients

open access: yesAl-Mustansiriyah Journal of Pharmaceutical Sciences, 2012
The presented study focuses on the main role of leptin and lipid profile level in Iraqi patients with unstable angina to indicate the main risk factors that play a role with their elevation. This is a case control study conducted on (37) unstable angina
Ammal E. Ibrahim   +2 more
doaj   +1 more source

Xuesaitong Soft Capsule (Chinese Patent Medicine) for the Treatment of Unstable Angina Pectoris: A Meta-Analysis and Systematic Review

open access: yesEvidence-Based Complementary and Alternative Medicine, 2013
Objective. To provide a systematic review to evaluate the effectiveness and safety of Xuesaitong soft capsule (XST) in treating unstable angina (UA). Methods. An extensive search of 6 medical databases was performed up to August 2013.
Xiaochen Yang   +4 more
semanticscholar   +1 more source

Unstable angina pectoris

open access: yesClinical Cardiology, 1990
AbstractThe pathophysiology of unstable angina has been better elucidated in the past five years and has led to more rational therapy. Coronary arteries in patients with unstable angina have atherosclerotic plaques which are often complex and are the site of platelet activation and fibrin deposition.
P. N. Yu, W. A. Wallace, J. F. Richeson
openaire   +3 more sources

Diagnostic Potential of Plasmatic MicroRNA Signatures in Stable and Unstable Angina

open access: yesPLoS ONE, 2013
Purpose We examined circulating miRNA expression profiles in plasma of patients with coronary artery disease (CAD) vs. matched controls, with the aim of identifying novel discriminating biomarkers of Stable (SA) and Unstable (UA) angina.
Y. D'Alessandra   +12 more
semanticscholar   +1 more source

Materials Advances in Devices for Heart Disease Interventions

open access: yesAdvanced Materials, EarlyView.
This review examines the crucial role of materials in heart disease interventions, focusing on strategies for monitoring, managing, and repairing heart conditions. It discusses the material requirements for medical devices, highlighting recent innovations and their impact on cardiovascular health.
Gagan K. Jalandhra   +11 more
wiley   +1 more source

LncRNA Foxo6os as a Novel “ Scaffold” Mediates MYBPC3 in Combating Pathological Cardiac Hypertrophy and Heart Failure

open access: yesAdvanced Science, EarlyView.
Schematic overview showing that forkhead box O6, opposite strand (Foxo6os) acts as a “scaffold”, directly binding myosin‐binding protein‐C (MYBPC3) and recruiting protein kinase C (PKC‐α) to mediate site‐specific phosphorylation of MYBPC3. This post‐translational modification supports cardiac contraction by regulating L‐type Ca2+ channels, especially ...
Jie Sheng   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy